Overall survival in COLUMBUS: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma.

Author:

Dummer Reinhard1,Ascierto Paolo Antonio2,Gogas Helen3,Arance Ana M.4,Mandalà Mario5,Liszkay Gabriella6,Garbe Claus7,Schadendorf Dirk8,Krajsova Ivana9,Gutzmer Ralf10,Chiarion-Sileni Vanna11,Dutriaux Caroline12,de Groot Jan Willem13,Yamazaki Naoya14,Loquai Carmen15,De Parseval Laure A.16,Pickard Michael D17,Sandor Victor18,Robert Caroline19,Flaherty Keith20

Affiliation:

1. University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland;

2. National Tumour Institute Fondazione G. Pascale, Naples, Italy;

3. First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece;

4. Hospital Clínic de Barcelona, Barcelona, Spain;

5. Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy;

6. National Institute of Oncology, Budapest, Hungary;

7. Eberhard Karls University, Tübingen, Germany;

8. Department of Dermatology, University of Duisburg-Essen, Essen, Germany;

9. Charles Univ and VFN, Prague, Czech Republic;

10. Skin Cancer Center Hannover, Department of Dermatology, Hannover Medical School, Hannover, Germany;

11. Veneto Oncology Research Institute, Padua, Italy;

12. Dermatology and Pediatric dermatology department, Bordeaux hospital, Bordeaux, France, Bordeaux, France;

13. Isala Clinics, Zwolle, Netherlands;

14. Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan;

15. University Medical Center Mainz, Mainz, Germany;

16. Novartis Pharma AG, Basel, Switzerland;

17. Array BioPharma Inc., Boulder, CO;

18. Array BioPharma, Cambridge, MA;

19. Gustave Roussy Institute, Paris, France;

20. Massachusetts General Hospital, Boston, MA;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3